ArticleBiomimetics (Basel, Switzerland)2026
Multi-Strategy Improved Red-Billed Blue Magpie Optimization Algorithm and Its Engineering Applications.
Article in Biomimetics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- A Multi-Strategy Improved Dung Beetle Optimizer for High-Dimensional Optimization and Engineering Applications.Biomimetics (Basel, Switzerland) · 2026Article
- Enhanced Multi-Strategy Improved Animated Oat Optimization Algorithm and Its Engineering Application.Biomimetics (Basel, Switzerland) · 2026Article
- Ivy Optimization Algorithm Combining Sine-Cosine Operator and Adaptive T-Distribution and Its Engineering Application.Biomimetics (Basel, Switzerland) · 2026Article
- Hybrid Strategy Improved Horned Lizard Optimization Algorithm for Advanced Global Optimization and Engineering Applications.Biomimetics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
In response to the decline in population diversity, the imbalance between exploration and exploitation, and the low convergence efficiency in the middle and later stages of the Red-billed Blue Magpie Optimizer (RBMO) when addressing complex optimization problems, this study proposes a multi-strategy enhanced variant termed CLD-RBMO. The proposed algorithm improves the original search mechanism from three perspectives: strengthened global exploration, enhanced local refinement, and directed exploitation in the middle and later stages. During the exploration phase, a hierarchical perturbation mechanism based on Logistic chaotic mapping and Lévy flight is introduced to enhance randomness and spatial coverage in the early search process. In the local exploitation phase, a Cauchy-Gauss hybrid mutation operator is employed to improve the algorithm's capability to escape from local optima. In the middle and later search stages, a stochastic differential mutation strategy is incorporated to provide population-structure-based directional guidance for individuals, thereby accelerating convergence and improving optimization accuracy. Simulation results on the CEC2017 benchmark test functions indicate that CLD-RBMO demonstrates clear superiority over the original algorithm and several representative swarm intelligence optimization algorithms in terms of optimization accuracy, stability, and overall performance ranking. Convergence curve analysis confirms its dynamic performance improvements across different search stages, and the Wilcoxon rank-sum test further statistically validates the significance of the performance enhancement achieved by the proposed improvements compared with the original algorithm. Moreover, evaluations on two representative mechanical engineering optimization case studies further demonstrate the algorithm's strong stability and engineering generalization capability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.